|167.37||-3.21||-1.88%||Vol 156.88K||1Y Perf 27.30%|
|Feb 3rd, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||120.00||Analyst Rating||Strong Buy 1.00|
|Potential %||-28.30||Finscreener Ranking||★+ 43.25|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||★ 40.41|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||★★★ 50.41|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||— -|
|Price Range Ratio 52W %||90.80||Earnings Rating||Sell|
|Market Cap||5.97B||Earnings Date||1st Mar 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||1st Mar 2023|
|Estimated EPS Next Report||0.69|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||119.74K|
|Avg. Monthly Volume||99.97K|
|Avg. Quarterly Volume||138.33K|
Novanta Inc. (NASDAQ: NOVT) stock closed at 167.37 per share at the end of the most recent trading day (a -1.88% change compared to the prior day closing price) with a volume of 156.88K shares and market capitalization of 5.97B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Hardware industry, Technology sector and employs 2290 people. Novanta Inc. CEO is Matthijs Glastra.
The one-year performance of Novanta Inc. stock is 27.3%, while year-to-date (YTD) performance is 23.18%. NOVT stock has a five-year performance of 200.48%. Its 52-week range is between 110.84 and 173.1, which gives NOVT stock a 52-week price range ratio of 90.80%
Novanta Inc. currently has a PE ratio of 67.80, a price-to-book (PB) ratio of 9.11, a price-to-sale (PS) ratio of 7.71, a price to cashflow ratio of 62.90, a PEG ratio of 2.32, a ROA of 6.50%, a ROC of 7.11% and a ROE of 15.02%. The company’s profit margin is 9.15%, its EBITDA margin is 18.50%, and its revenue ttm is $642.53 Million , which makes it $18.00 revenue per share.
Of the last four earnings reports from Novanta Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.69 for the next earnings report. Novanta Inc.’s next earnings report date is 01st Mar 2023.
The consensus rating of Wall Street analysts for Novanta Inc. is Strong Buy (1), with a target price of $120, which is -28.30% compared to the current price. The earnings rating for Novanta Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Novanta Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Novanta Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.85, ATR14 : 4.85, CCI20 : 131.07, Chaikin Money Flow : 0.33, MACD : 6.05, Money Flow Index : 73.21, ROC : 10.15, RSI : 67.96, STOCH (14,3) : 77.90, STOCH RSI : 0.50, UO : 66.75, Williams %R : -22.10), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Novanta Inc. in the last 12-months were: Brian S. Young (Option Excercise at a value of $681 079), Frank Anders Wilson (Option Excercise at a value of $0), Katherine A. Owen (Option Excercise at a value of $0), Lonny J. Carpenter (Option Excercise at a value of $0), Matthijs Glastra (Option Excercise at a value of $2 684 328), Matthijs Glastra (Sold 33 000 shares of value $5 157 426 ), Maxine Lum Mauricio (Option Excercise at a value of $0), Peter Chang (Option Excercise at a value of $271 374), Peter L. Chang (Option Excercise at a value of $271 374), Robert J. Buckley (Option Excercise at a value of $1 101 951), Robert J. Buckley (Sold 20 320 shares of value $2 979 350 ), Thomas N. Secor (Option Excercise at a value of $0), Thomas N. Secor (Sold 1 100 shares of value $145 750 )
Tue, 15 Nov 2022 02:02 GMT Analysts Conflicted on These Technology Names: Novanta (NOVT) and Health Catalyst (HCAT)- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.